The Top 25 Healthcare Technology Leaders of Jacksonville for 2022

The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of Jacksonville for 2022. The city of Jacksonville, Florida is home to the headquarters of three Fortune 500 companies and boasts an unemployment rate nearly a full percentage point below the national average. A major factor in the local economy is the healthcare industry, as evidenced by the four nonprofit healthcare organizations that call the city home and the wide array of public and private healthcare companies based in the city. These companies not only help to drive the local economy, they also provide invaluable, cutting-edge healthcare solutions that enable patients to live healthier, longer lives, and the leaders on this year’s list play a large role in their success.

Some of this year’s standouts include Lisa Ashby, CEO of Carestream Dental, which is transforming dentistry with its advanced digital dental and imaging solutions across an array of equipment, software, and systems. Meanwhile, Zimmer Biomet and President of Trauma, CMFT, Foot and Ankle Brian Hatcher are furthering the company’s mission to alleviate pain and improve the quality of life for patients with its comprehensive portfolio of innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics, and artificial intelligence. And CEO Aure Bruneau’s Stimwave is revolutionizing wireless microsize injectable medical devices for neurology markets, relieving patients’ pain with its two types of neurostimulator devices that block pain signals from reaching the brain.

The companies represented on this year’s list run the gamut of specialties in the healthcare industry, from dental solutions to molecular diagnostics, tissue repair, radiotherapy, and much more. What they share is their clear commitment and dedication to improving the lives and health of patients not just in Jacksonville, but in the rest of the country and around the world, through their innovative solutions to life-altering health challenges. Please join us in celebrating The Top 25 Healthcare Technology Leaders of Jacksonville for 2022.

 

1. Lisa Ashby
Company: Carestream Dental
Title: Chief Executive Officer

Lisa Ashby is the Chief Executive Officer of Carestream Dental. She first joined the company as President in 2015. Carestream Dental is transforming dentistry, simplifying technology and changing lives around the world with innovative digital dental systems, solutions, and support. From intraoral and extraoral imaging equipment to CAD/CAM solutions, imaging analysis software and practice management systems, practitioners rely on Carestream Dental to drive transformation in the industry. Carestream Dental technology captures two billion images annually and helps practitioners deliver more precise diagnoses, improved workflows, and superior patient care.

Previously, Ashby was President of Medical Devices and Diagnostics at Cardinal Health, and before that, Vice President of Distribution Channel and Services at Allegiance Healthcare. Earlier in her career, she worked with Baxter as a Director. Ashby earned an undergraduate degree in computer science, public policy, and psychology from Duke University.

 

2. Brian Hatcher
Company: Zimmer Biomet
Title: President, Trauma, CMFT, Foot and Ankle

Brian Hatcher is the President, Trauma, CMFT, Foot and Ankle at Zimmer Biomet, a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. It advances its mission to alleviate pain and improve the quality of life for patients around the world with its innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics, and artificial intelligence. Founded in 1927, Zimmer Biomet has operations in more than 25 countries and sales in more than 100 countries. It maintains world-class scientific facilities and resources, and collaborates with leading clinicians and researchers around the world.

Before joining Zimmer Biomet, Hatcher was Director of Research for Biomet, and before that a senior program manager at Medtronic. Earlier in his career, he worked with OrbusNeich as an engineer. Hatcher graduated from the University of Florida with a PhD in biomedical engineering and an undergraduate degree in chemistry.

 

3. Michael Sirotovitch
Company: Berlin-Chemie AG
Title: Chief Operating Officer

Michael Sirotovitch is the Chief Operating Officer of Berlin-Chemie AG, an international research-based pharmaceutical company that develops, produces, and sells pharmaceutical products. It aims to stay up to date on the continuous progress being made in evidence-based medicine and to identify possibilities where its products can make a real difference in improving the lives of patients.

Berlin-Chemie AG has subsidiaries in more than 25 countries in Europe and Asia. Since 1992, it has been part of the Italian Menarini Group, a leading global family-owned pharmaceutical and diagnostics company with a presence in more than 100 countries. Within the Menarini Group, Berlin-Chemie is responsible for the pharmaceutical business in Germany, Eastern Europe, and the CIS region. Sirotovitch graduated from Columbia University in the City of New York with an MBA in general management and international business.

 

4. Jacob Paul
Company: Corin Group
Title: Chief Executive Officer

Jacob Paul is the Chief Executive Officer of Corin Group. He first joined the company in 2021. As a leader in orthopedic innovation, Corin has pioneered a number of landmark developments since its founding and is proud to have been able to improve the quality of life of thousands of patients around the world through these groundbreaking products. The company’s talented and dedicated teams share a common commitment to deliver quality orthopedic products and services to patients, surgeons, and healthcare providers which exceed expectations and positively impact lives. Corin’s product portfolio is designed to provide each patient with the optimal solution, utilizing some of the most advanced technologies available in the world to enhance implant longevity and performance.

Previously, Paul was a Senior Vice President and President of Cranial and Spinal Technologies at Medtronic, and before that, a P&L Finance Manager at Intel. Earlier in his career, he worked with CEAT as a planning and control engineer. Paul earned an MBA from Indiana University - Kelley School of Business, an MMS in operations from S.P. Jain Institute of Management and Research, and an undergraduate degree in engineering from the University of Mumbai.

 

5. Gaspar Zuniga
Company: Johnson & Johnson
Title: Vice President, Vision Supply Chain

Gaspar Zuniga is the Vice President, Vision Supply Chain for Johnson & Johnson. Founded in 1886, Johnson & Johnson is one of the oldest pharmaceutical companies in the country, and one of the world's most valuable companies. It is also one of only two U.S.-based companies that have a prime credit rating of AAA, higher than that of the United States government. Known for developing medical devices, pharmaceuticals, and consumer packaged goods, J&J is home to well-known products including Band-Aid bandages, Tylenol pain medications, Neutrogena skin and body products, and Acuvue contact lenses. Johnson & Johnson maintains operations in 60 countries, while its roughly 250 subsidiaries and their products are sold in more than 175 countries.

Before joining J&J, Zuniga was Head of Pharma Supply Chain - North America at Novartis, and before that, VP of Technical Operations at Sandoz. Earlier in his career, he worked with McNeil Pharmaceutical as a senior inventory analyst. Zuniga graduated from the University of Michigan - Stephen M. Ross School of Business with an MBA and from the Georgia Institute of Technology with an undergraduate degree in industrial engineering.

 

6. Brad Thomas
Company: IQVIA
Title: Vice President and Global Head of Med Tech Clinical Solutions

Brad Thomas is the Vice President and Global Head of Med Tech Clinical Solutions at IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources, and extensive domain expertise. With approximately 79,000 employees, IQVIA conducts operations in more than 100 countries. The company also uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes.

Prior to IQVIA, Thomas was a director of operations, quality and regulatory manager, and director of product marketing for Orthomatrix Inc. From there he went on to Medtronic, before eventually rising to general manager at RTI Surgical, his most recent position prior to joining IQVIA. Thomas graduated from Louisiana State University - Shreveport with an MBA and from Christian Brothers University with an undergraduate degree in marketing management.

 

7. Steve Tarantino
Company: McKesson
Title: Vice President of Operations

Steve Tarantino is the Vice President of Operations for McKesson. He first joined the company in 2013. McKesson Corp. is one of the largest providers of medicines, pharmaceutical supplies, and health information technology products and services in the United States. The company was founded in 1833 with a focus on importing and wholesaling pharmaceutical products. Today, as a global healthcare company, McKesson touches virtually every aspect of health.

McKesson works with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services that make quality care more accessible and affordable. Its leaders empower its people to lead with a growth mindset and deliver excellence for its customers, partners, and the wellbeing of people, everywhere – delivering better health outcomes for its employees, its communities, and its environment. Every day, McKesson strives to inspire and enable people to reach their full potential.

 

8. Aure Bruneau
Company: Stimwave
Title: Chief Executive Officer

Aure Bruneau is the Chief Executive Officer of Stimwave, a privately-held medical device company engaged in the development, manufacture, commercialization, and marketing of wireless microsize injectable medical devices for neurology markets. It strives to improve people’s lives through its two types of neurostimulator devices that provide long-lasting pain relief: Freedom SCS System and StimQ PNS System. These systems relieve pain by sending electrical stimulation to block those pain signals from reaching the brain. Unlike any other device, Stimwave is powered wirelessly and without an implanted battery. Stimwave enables low cost alternatives to complicated and expensive surgery, coupled with convenient and safe methods of use easily incorporated into everyday life.

Before joining Stimwave, Bruneau was a Group President Spine, CMF & Thoracic, and Surgery Assisting Technologies (Robotic) at Zimmer Biomet, and before that, a General Manager at Biomet Microfixation. Earlier in his career, he worked with Medtronic Sofamor Danek as a product manager of Asia, Americas, and Pacific Region. Bruneau graduated from The University of Memphis.

 

9. Valan Joseph
Company: Viatris
Title: Vice President and Global Head of ERP and Finance Applications

Valan Joseph is the Vice President and Global Head of ERP and Finance Applications at Viatris, a new kind of global healthcare company that is empowering people worldwide to live healthier at every stage of life. Viatris provides access to medicines, advances sustainable operations, develops innovative solutions, and leverages its collective expertise to connect more people to more products and services through its one-of-a-kind Global Healthcare Gateway®. The company brings together scientific, manufacturing, and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories.

Prior to Viatris, Joseph was a senior manager at Ranbaxy before eventually rising to VP and Global IT Head of ERP, Integration, and Analytics at Mylan, his most recent position prior to joining Viatris. Joseph graduated from Chifley Business with an MBA and from Madurai Kamaraj University with an undergraduate degree in engineering.

 

10. Brett Nagy
Company: Varian
Title: Vice President of North America Sales

Brett Nagy is the Vice President of North America Sales for Varian. He first joined the company in 2012 as surgical sciences district manager. Varian designs, manufactures, sells, and services medical equipment. It offers radiotherapy, radiosurgery, X-ray tube technology, digital image detectors, cargo screening, and non-destructive testing equipment. Varian serves the healthcare sector globally. It has developed, built, and delivered innovative cancer care technologies and solutions for its clinical partners around the globe for more than 70 years, helping them treat millions of patients each year.

With an Intelligent Cancer Care approach, Varian is harnessing advanced technologies like artificial intelligence, machine learning, and data analytics to enhance cancer treatment and expand access to care. Its 10,000 employees across 70 locations keep the patient and its clinical partners at the center of its thinking as it powers new victories in cancer care. Previously, Nagy was an area sales manager at BrainLAB. He earned an undergraduate degree in marketing from Jacksonville University.

 

11. Brendan Lyden
Company: Varian
Title: Vice President of Global Field Operations of Varian Proton Solutions

Brendan Lyden is the Vice President of Global Field Operations of Varian Proton Solutions at Varian. For more than 70 years, Varian has developed, built, and delivered innovative cancer care technologies and solutions for its clinical partners around the globe to help them treat millions of patients each year. With an Intelligent Cancer Care approach, the company is harnessing advanced technologies like artificial intelligence, machine learning, and data analytics to enhance cancer treatment and expand access to care. Its 10,000 employees across 70 locations keep the patient and Varian’s clinical partners at the center of its thinking as it powers new victories in cancer care. Varian envisions a world without fear of cancer.

Before joining Varian, Lyden was a project director at IBA, and before that, a health and safety technician II at Yale University. He graduated from Jacksonville University with an MBA and from Southern Connecticut State University with an undergraduate degree in physics.

 

12. Laura Williams
Company: CooperVision
Title: Vice President of Regulatory Affairs

Laura Williams is the Vice President of Regulatory Affairs at CooperVision, one of the world’s leading manufacturers of soft contact lenses. It produces a full array of monthly, two-week, and daily disposable contact lenses, all featuring advanced materials and optics. A unit of The Cooper Companies, Inc., CooperVision has a strong heritage of solving the toughest vision challenges, such as astigmatism and presbyopia, and offers the most complete collection of spherical, toric, and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers.

Williams first got her start in 1993 as a project engineer at Baxter Healthcare. From there, she went on to Zimmer, Inc., before eventually rising to VP of Regulatory Affairs at Exactech, her most recent position prior to joining CooperVision. Williams graduated from Indiana Wesleyan University with an MS in management, and from Purdue University with an undergraduate degree in mechanical engineering.

 

13. Keith Arnold
Company: Healogics
Title: Senior Vice President of Business Development

Keith Arnold is the Senior Vice President of Business Development at Healogics. He first joined the company in 2012. Healogics, LLC is the nation’s wound healing expert. The Healogics team is made up of nearly 3,000 employees, 4,000 affiliated physicians, and a Healogics Specialty Physician practice group of almost 300. In addition to its network of outpatient centers, Healogics partners with more than 300 skilled nursing facilities to care for patients with chronic wounds, and provides inpatient consults at more than 80 partner hospitals. As the industry leader, Healogics has the largest repository of chronic wound-specific patient data in the country. The Healogics Wound Science Initiative, an effort launched in 2017 to provide peer-reviewed research, recognizes the value and relevance of big data and advanced analytics to drive continuous, collaborative learning towards a better understanding of how to efficiently utilize healthcare resources for patients with wounds.

Previously, Arnold was VP of Corporate Accounts at ArjoHuntleigh, and before that, a regional sales director at the United States Surgical Corporation. He earned an undergraduate degree in marketing from Georgia State University.

 

14. Aaron Berutti
Company: Treace Medical Concepts, Inc.
Title: Senior Vice President of Sales

Aaron Berutti is the Senior Vice President of Sales at Treace Medical Concepts, Inc., a commercial-stage orthopedic medical device company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot. Treace has pioneered and patented the Lapiplasty® 3D Bunion Correction™ system – a combination of instruments, implants, and surgical methods designed to correct all 3 planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. Treace recently expanded its offering with the Adductoplasty™ Midfoot Correction System, designed for reproducible correction of the midfoot, which could provide further support to hallux valgus patients.

Before joining Treace Medical Concepts, Berutti was VP of Sales & Marketing, Extremities for the U.S. and Canada at Orthofix, and before that, VP of Business Development at Cartiva, Inc. Earlier in his career, he worked with Arthrex as a corporate sales manager. Berutti graduated from Indiana University - Kelley School of Business with an MBA and an MS in management and finance, and from Vanderbilt University with an undergraduate degree in mechanical engineering.

 

15. Robert Geiger
Company: AmbioPharm
Title: Senior Vice President of Business Development

Robert Geiger is the Senior Vice President of Business Development at AmbioPharm, a global peptide CDMO specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at very small to very large scales. Founded in 2005, Ambio is a drug development company with a rich and growing pipeline of proprietary drug development programs for bioequivalent and biosimilar versions of the world’s best-selling peptide drugs.

Geiger first got his start in 1998 as a scientist II at UCB Chemicals. From there, he went on to UCB Bioproducts, before eventually co-founding AmbioPharm, Inc. He is also an associate professor for the University of Georgia College of Pharmacy. Geiger graduated from the Georgia Institute of Technology with a PhD in chemistry, from the Kennesaw State University - Michael J. Coles College of Business with an MBA, and from Hampden-Sydney College with an undergraduate degree in chemistry.

 

16. Daryl Fallon
Company: Premier Research
Title: Vice President of Proposal Development

Daryl Fallon is the Vice President of Proposal Development at Premier Research. She first joined the company in 2006 as Executive Director of Global Proposal Development. Premier Research is a provider of project management, clinical research, and monitoring services for pharmaceutical and medical device companies. Its deep, focused expertise targets the therapeutic areas and indications where today’s biotech and specialty pharma pioneers are doing the most amazing work. It is 1,500 employees strong and operates in more than 20 countries, delivering unmatched expertise, operational skills, and dedication to meeting customers’ most challenging needs. Premier Research has the brightest minds in clinical development today, people who apply their best thinking to every project, recognizing that what they do significantly affects the lives and well-being of customers, patients, physicians, and colleagues.

Previously, Fallon was a director of proposal development at SCIREX. Earlier in her career, she worked with Covance as a manager of proposal development. Fallon earned an undergraduate degree in business, management, marketing, and related support services from Drexel University.

 

17. Laura Zurlinden
Company: PCI Pharma Services
Title: Vice President of North American Business Development and Clinical Services

Laura Zurlinden is the Vice President of North American Business Development and Clinical Services for PCI Pharma Services, a leading provider of integrated pharmaceutical development services to the global healthcare market, including analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, as well as QP services, supply chain management, storage, and distribution to the healthcare industry. With facilities in North America and Europe, PCI supports pharmaceutical and biotech companies with products destined for more than 100 countries around the world. It provides services for each stage of the product lifecycle from early Phase I through commercial launch and long-term supply, and partners with customers to provide key insights and expertise in enabling successful commercialization and bringing life-saving medications to patients.

Before joining PCI Pharma Services, Zurlinden was a senior account director of clinical supply services at Catalent Pharma Solutions, and prior to that, an account executive at Sharp Corporation. Earlier in her career, she worked with Bemis Company, Inc. as an account manager. Zurlinden graduated from Michigan State University with an undergraduate degree in packaging.

 

18. Vince Miranda
Company: One Call
Title: Vice President of Compliance

Vince Miranda is the Vice President of Compliance at One Call. For more than 30 years, One Call has served the workers’ compensation industry by arranging care for injured workers in partnership with its clients. As a leader within a complex industry, it is committed to streamlining the claims process. The company starts by creating a customized recovery plan for each injured worker, combining data and analytics with a holistic view of their physical, mental, and emotional health. From there, it utilizes technology to connect injured workers with high-quality providers within its expansive network and across its comprehensive core solutions. One Call alleviates costs and burdensome administrative work for its clients, and positions injured workers for high quality of life and long-term success, both in and out of the workplace. One Call’s dedication consistently earns the respect of its clients who trust it to coordinate care for one million injured workers each year.

Prior to One Call, Miranda served as manager of reporting and receivables at MSC Care Management. He graduated from the University of North Florida with an undergraduate degree in business administration and management.

 

19. Karen Galambos
Company: PTC Therapeutics
Title: Vice President of Patient Relations

Karen Galambos is the Vice President of Patient Relations at PTC Therapeutics. She first joined the company in 2015 as patient advocacy liaison. PTC is a science-driven, patient-centered biopharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy that regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders like nonsense mutations in Duchenne muscular dystrophy and oncology.

Previously, Galambos was an associate director of patient advocacy at Shire, and before that, a principal at Right Type Pro. Earlier in her career, she worked with MAG Mutual as a medical claims liaison. Galambos earned an undergraduate degree in psychology from Jacksonville University.

 

20. Steve Raters
Company: Luminex Corporation
Title: Vice President of Customer Service Operations NA

Steve Raters is the Vice President of Customer Service Operations NA at Luminex Corporation. Luminex’s mission is to empower labs to obtain reliable, timely, and actionable answers, thereby ultimately advancing health. It offers a wide range of solutions applicable in diverse markets, including clinical diagnostics, pharmaceutical drug discovery, biomedical research, flow cytometry and imaging, genomic and proteomic research, and food safety. It aims to accelerate reliable answers while simplifying complexity and delivering certainty with a seamless experience. Luminex offers comprehensive and innovative technical support and hands-on field training to optimize experiences with Luminex systems.

Before joining Luminex Corporation, Raters was VP of Global Customer Support at Rapid Micro Biosystems, and prior to that, senior director of service transformation - Latin America at bioMerieux. Earlier in his career, he worked with the U.S. Navy as a naval electronics technician (SS) E-6. Raters graduated from the University of Phoenix with an MBA.

 

21. Christian Whitney
Company: Medtronic
Title: Director of Toxicology and Biocompatibility

Dr. Christian Whitney has over 19 years of experience as a toxicologist and currently serves as the Director of Toxicology and Biocompatibility at Medtronic plc. He oversees a global toxicology and biocompatibility department and supports hazardous substances and materials of concern compliance programs, moving the company towards higher quality, safer, greener products while simultaneously generating millions in cost savings through improvements in connecting people, process, and technology. At Medtronic, he has a proven track record of providing creative solutions for the registration of innovative devices that improve the quality of healthcare for patients across the world.

Whitney received a Ph.D. in Molecular Toxicology from the Department of Environmental Medicine at the University of Rochester. He is the recipient of three national awards for work in Medical Device Toxicology since 2015 and has over 50 publications, seminars, and invited talks. He is the Industry Representative for the Immunology Devices Panel of the Medical Devices Advisory Committee in FDA's Center for Devices and Radiological Health. He is also a member of MedTech Europe’s Chemicals Working Group and MDR Substances Ad Hoc Working Group as well as a member of the AdvaMed Biocompatibility Working Group. Whitney serves as a member of the Mutagenicity, Carcinogenicity, and Reproductive Toxicity Working Group (ISO/TC 194/WG 6) within the Association for the Advancement of Medical Instrumentation. He is a full member of the Society of Toxicology and is a member of the Metals, Risk Assessment, Regulatory and Safety Evaluation, and Medical Device & Combination Product Specialty Sections, the latter of which he is the Past President. In addition, he is currently serving as the President-Elect of the Southeastern Regional Chapter of the Society of Toxicology.

 

22. David Hummell
Company: CareDx, Inc.
Title: Vice President of Digital Sales and Marketing

David Hummell is the Vice President of Digital Sales and Marketing at CareDx, Inc. He first joined the company in 2021. CareDx, Inc. is dedicated to improving the lives of organ transplant patients through non-invasive diagnostics. By combining the latest advances in genomics and bioinformatics technology with a commitment to generating high quality clinical evidence through trials and registries, CareDx is at the forefront of organ transplant surveillance and pre-transplant HLA typing solutions. Its understanding of transplant patients and care teams allows it to develop solutions to extend graft life. With two decades of commitment to transplant care, CareDx has developed close partnerships across the transplant ecosystem that grow stronger every day.

Previously, Hummell was a sales & marketing leader at Johnson & Johnson. He earned an MBA from The Ohio State University Fisher College of Business and an undergraduate degree in economics from the United States Naval Academy.

 

23. Oystein Valberg
Company: Collagen Matrix, Inc.
Title: Chief Financial Officer

Oystein Valberg is the Chief Financial Officer for Collagen Matrix, Inc. Collagen Matrix is passionate about advancing the science of tissue repair and regeneration. That’s why it’s the driving force in the design, development, and manufacturing of advanced collagen and mineral based medical devices that support the body’s natural ability to regenerate. Since its inception in 1997, Collagen Matrix has been awarded significant grant money for the research and development of collagen based matrix products. It has expanded into two facilities with nearly 200 employees and has commercialized more than 50 medical devices for its five business units – Dental, Spine, Orthopedic, Dural Repair, and Nerve Repair. Its products are now distributed around the world via a substantial global distribution network.

Before joining Collagen Matrix, Inc., Valberg was CFO and VP of Finance, Strategy, and Business Development at Medtronic, and prior to that, a senior financial analyst at US Bank. Earlier in his career, he worked with Grant Thornton as a CPA and senior auditor. Valberg graduated from the University of Minnesota - Carlson School of Management with an MBA and an undergraduate degree in finance.

 

24. Amy Desiderio
Company: ZimVie
Title: Vice President of Transformation

Amy Desiderio is the Vice President of Transformation for ZimVie, a global life sciences leader in the dental and spine markets that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to treat a wide range of spine pathologies and support dental tooth replacement and restoration procedures. The company was founded in March 2022 as an independent, publicly-traded spin-off of the Dental and Spine business units of Zimmer Biomet to breathe new life, dedicated energy, and strategic focus to its portfolio of trusted brands and products. The company serves customers in more than 70 countries worldwide with a robust offering of dental and spine solutions, including differentiated product platforms supported by extensive clinical evidence.

Desiderio first got her start in 1998 as a publisher and producer at Lithographic Services Inc. From there, she went on to Paramount Performance Marketing, before eventually rising to VP of the Transformation Office for NewCo at Zimmer Biomet, her most recent position prior to joining ZimVie. Desiderio graduated from Louisiana State University - Shreveport with an MBA, and from the University of Florida with an undergraduate degree in advertising, business, and marketing.

 

25. Mark Rayan
Company: mdxhealth
Title: Senior Vice President of Managed Care and Reimbursement Strategy

Mark Rayan is the Senior Vice President of Managed Care and Reimbursement Strategy at mdxhealth. He first joined the company in 2015. mdxhealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation), and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy.

Previously, Rayan was senior national director of managed care, government and strategic accounts at CardioDx, and before that, global director of managed care of Eastern North America and Europe at Agendia Inc. Earlier in his career, he worked with Integrated Health Services as a director of marketing and admissions. Rayan earned an undergraduate degree in healthcare management from Southern Illinois University, Carbondale.